How to prevent and deal with bacterial vaginosis

Bacterial vaginosis (BV) has been classified as a “women’s health problem” for decades. Influences nearly 30% of vaginal patients in the United States, it has long been considered an imbalance of vaginal flora characterized by unpleasant emissions and odors. But a groundbreaking study published in the New England Journal of Medicine challenged the framework and could change forever how we understand vaginal conditions.

Quick Review: What is BV?

Bacterial vaginosis (BV) occurs when the vaginal microbiome is imbalanced – especially when healthy Lactobacillus (good bacteria that help keep vagina acidic) are reduced and replaced by overgrowth of anaerobic bacteria. Although many people do not experience obvious symptoms, this damage can lead to symptoms such as inflammation and symptoms. It is important to note that BV is not caused by a single bacterial or classical infection and is not considered a sexually transmitted infection (STI) – still conducting sexual activities such as not using condoms, and having a new or multiple sexual partners often triggers or worsens this condition.

BV can cause symptoms such as:

• Thin, off-white emissions
• Fishy vagina smell
• Vaginal irritation or burning
• Pain during urination

However, many people with BV have no symptoms. The remaining untreated, BV can increase the risk of premature birth, pelvic inflammatory disease and increase sensitivity to sexually transmitted infections such as HIV.

Big transformation: What has new research discovered

When a partner has bacterial vaginosis (BV), the randomized controlled trial examined the effects of both men and women. In the trial, male partners received oral metronidazole and topical clindamycin (applied to the penis), while female partners received standard BV treatment.

After 12 weeks, the study concluded that only 35% of women had BV relapse with their male partners. On the other hand, 63% of women treated alone experienced recurrence of infection.

Why is this important?

Traditionally, BV has been seen as a microbial problem that is isolated from the vagina. Treatment guidelines do not include male partners, mainly because men do not show symptoms. However, this study shows that male partners can act as reservoirs of BV-related bacteria, reintroducing them unconsciously during sex.

Pherdal CEO and founder, Dr. Jennifer Hintzsche, Ph.D., agreed: “This study confirms what many women and clinicians have long suspected that BV is not just the vaginal microbiome, it can also be a common condition between partners.

BV usually occurs shortly after sexual intercourse, which is why it is suspected to be a sexually transmitted infection (STI). But so far, studies on treating antibiotic partners have not shown a expected decline in recurrence rates. This is the first study to combine both oral and topical antibiotics with male partners. This combined approach can target BV bacteria that can survive inside the urethra and in the penis skin. ”

Rethinking Sexual Health Dialogue

This study is of great significance to how we approach BV, not only in clinical care, but also in coping with social stigma. Women have long had to deal with concerns about repeated infections, often feeling frustrated and even shamed. Many people report treating BV over and over again, but it returns within weeks or months due to untreated male partners. “With all antibiotic treatments, it’s important for patients to follow medication guidelines and take a full dose. If you kill 99% of bacteria with only antibiotics, this means that 1% of the remaining bacteria have now survived the first dose of antibiotics and become resistant,” Hintzsche explained. She also noted that the preferred treatment for BV is antibiotics, such as metronidazole or clindamycin, which is usually prescribed only for women. However, the focus of the study is on treatment for both parties.

Now, there is solid evidence that involvement of male partners in treatment can greatly reduce these recurrences. This may result in:

• Update on BV treatment options
• A broader education on the common nature of BV risks
• Reduced stigma of people who have repeatedly affected

First of all, how to help prevent BV

While these findings are games that change game therapy, they also provide revelation for prevention. Understanding that BV is not only related to individual hygiene, but also to a shared microbial environment, means that prevention efforts can go beyond basic knowledge. From supporting the vaginal microbiome to making smart choices about sex, there are some simple, proactive steps that one can take to reduce the risk of developing or redeveloping BV.

Methods to support the prevention of BV include:

• Avoid flushing: It can destroy the natural bacterial balance of the vagina and make you more susceptible to infection.
• Continuous use of condoms: Barrier protection can reduce the introduction of semen and bacteria that may interfere with vaginal pH.
• Practice good genital hygiene (no over-cleaning): Stick to warm and spice-free products designed for your vaginal area. (Hintzsche also recommends that men practice good hygiene to prevent repeated BV from occurring)
• Using demanding soap can irritate and destroy the microbiome.
• Restrict sexual partners and discuss any symptoms: New or multiple partners can introduce strange bacteria.
• Avoid smoking: Smoking is associated with a reduced level of vaginal protective Lactobacillus lactobacillus.
• Supports overall vaginal health: Combined with vaginal probiotics, e.g. Hum’s Private Party Can help maintain a healthy bacterial environment. This daily supplement contains three clinically studied strains Lactobacillus This works to maintain optimal pH levels, balance the vaginal microbiome and support the health function of the urinary tract.
• Stay in physical condition: If symptoms appear, early treatment can help prevent a full-scale infection or recurrence.

These steps don’t guarantee that you will never get BV, but they can help create a healthier environment where bacteria flourish, which is the best defense.